Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity.

Larson JD, Thurman JM, Rubtsov AV, Claypool D, Marrack P, van Dyk LF, Torres RM, Pelanda R.

Proc Natl Acad Sci U S A. 2012 May 1;109(18):E1092-100. doi: 10.1073/pnas.1203019109. Epub 2012 Apr 2.

2.

Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction.

Stocks BT, Wilhelm AJ, Wilson CS, Marshall AF, Putnam NE, Major AS, Moore DJ.

Am J Transplant. 2016 Jan;16(1):334-41. doi: 10.1111/ajt.13449. Epub 2015 Sep 15.

4.

Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.

Hutcheson J, Vanarsa K, Bashmakov A, Grewal S, Sajitharan D, Chang BY, Buggy JJ, Zhou XJ, Du Y, Satterthwaite AB, Mohan C.

Arthritis Res Ther. 2012 Nov 8;14(6):R243. doi: 10.1186/ar4086.

5.

The central and multiple roles of B cells in lupus pathogenesis.

Chan OT, Madaio MP, Shlomchik MJ.

Immunol Rev. 1999 Jun;169:107-21. Review.

PMID:
10450512
6.

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.

Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A.

Arthritis Res Ther. 2009;11(3):R79. doi: 10.1186/ar2710. Epub 2009 May 28.

7.

Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.

Singh RR, Ebling FM, Sercarz EE, Hahn BH.

J Clin Invest. 1995 Dec;96(6):2990-6.

8.

A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.

Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.

Immunol Lett. 2015 Dec;168(2):355-65. doi: 10.1016/j.imlet.2015.10.017. Epub 2015 Nov 3.

PMID:
26545567
9.

Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.

Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, Garlanda C, Mantovani A, Anders HJ.

J Exp Med. 2008 Aug 4;205(8):1879-88. doi: 10.1084/jem.20072646. Epub 2008 Jul 21. Erratum in: J Exp Med. 2008 Sep 1;205(9):2179.

10.
11.
12.

Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.

Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH.

J Immunol. 2007 Jun 15;178(12):8195-202.

13.

Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.

Peters AL, Stunz LL, Meyerholz DK, Mohan C, Bishop GA.

J Immunol. 2010 Oct 1;185(7):4053-62. doi: 10.4049/jimmunol.0904065. Epub 2010 Sep 1.

14.

Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice.

Fairhurst AM, Mathian A, Connolly JE, Wang A, Gray HF, George TA, Boudreaux CD, Zhou XJ, Li QZ, Koutouzov S, Banchereau J, Wakeland EK.

Eur J Immunol. 2008 Jul;38(7):1948-60. doi: 10.1002/eji.200837925.

15.
16.

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.

Bossù P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G, Dinarello CA, Di Carlo E, Musiani P, Meroni PL, Caselli G, Ruggiero P, Boraschi D.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14181-6. Epub 2003 Nov 13.

17.

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.

J Immunol. 2011 Sep 15;187(6):3413-21. doi: 10.4049/jimmunol.1101125. Epub 2011 Aug 17.

18.

Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.

Ichinose K, Zhang Z, Koga T, Juang YT, Kis-Tóth K, Sharpe AH, Kuchroo V, Crispín JC, Tsokos GC.

Arthritis Rheum. 2013 Mar;65(3):764-9. doi: 10.1002/art.37790.

20.

Type I IFN protects against murine lupus.

Hron JD, Peng SL.

J Immunol. 2004 Aug 1;173(3):2134-42.

Supplemental Content

Support Center